Correlation Between Enzymatica Publ and Enorama Pharma
Can any of the company-specific risk be diversified away by investing in both Enzymatica Publ and Enorama Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzymatica Publ and Enorama Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzymatica publ AB and Enorama Pharma AB, you can compare the effects of market volatilities on Enzymatica Publ and Enorama Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzymatica Publ with a short position of Enorama Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzymatica Publ and Enorama Pharma.
Diversification Opportunities for Enzymatica Publ and Enorama Pharma
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Enzymatica and Enorama is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Enzymatica publ AB and Enorama Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enorama Pharma AB and Enzymatica Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzymatica publ AB are associated (or correlated) with Enorama Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enorama Pharma AB has no effect on the direction of Enzymatica Publ i.e., Enzymatica Publ and Enorama Pharma go up and down completely randomly.
Pair Corralation between Enzymatica Publ and Enorama Pharma
Assuming the 90 days trading horizon Enzymatica publ AB is expected to generate 0.64 times more return on investment than Enorama Pharma. However, Enzymatica publ AB is 1.56 times less risky than Enorama Pharma. It trades about 0.01 of its potential returns per unit of risk. Enorama Pharma AB is currently generating about 0.0 per unit of risk. If you would invest 177.00 in Enzymatica publ AB on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Enzymatica publ AB or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 95.65% |
| Values | Daily Returns |
Enzymatica publ AB vs. Enorama Pharma AB
Performance |
| Timeline |
| Enzymatica publ AB |
| Enorama Pharma AB |
Enzymatica Publ and Enorama Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enzymatica Publ and Enorama Pharma
The main advantage of trading using opposite Enzymatica Publ and Enorama Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzymatica Publ position performs unexpectedly, Enorama Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enorama Pharma will offset losses from the drop in Enorama Pharma's long position.| Enzymatica Publ vs. Oncopeptides AB | Enzymatica Publ vs. Diamyd Medical AB | Enzymatica Publ vs. Kancera AB | Enzymatica Publ vs. Bonesupport Holding AB |
| Enorama Pharma vs. Cantargia AB | Enorama Pharma vs. Enzymatica publ AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. BioArctic AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |